size of infiltrate or scar, corneal structural integrity 6 months [clinicaltrials_resource:a9937baf5688c73aa9c00608e7a09b08]
patients not resolving to standard antifungal therapy were assigned to receive adjuvant collagen crosslinking with riboflavin and Ultraviolet-A along with topical medical therapy
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
size of infiltrate or scar, corneal structural integrity 6 months [clinicaltrials_resource:a9937baf5688c73aa9c00608e7a09b08]
patients not resolving to standard antifungal therapy were assigned to receive adjuvant collagen crosslinking with riboflavin and Ultraviolet-A along with topical medical therapy
Bio2RDF identifier
a9937baf5688c73aa9c00608e7a09b08
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a9937baf5688c73aa9c00608e7a09b08
measure [clinicaltrials_vocabulary:measure]
size of infiltrate or scar, corneal structural integrity
time frame [clinicaltrials_vocabulary:time-frame]
description
patients not resolving to stan ...... g with topical medical therapy
identifier
clinicaltrials_resource:a9937baf5688c73aa9c00608e7a09b08
title
size of infiltrate or scar, corneal structural integrity 6 months
@en
type
label
size of infiltrate or scar, co ...... 37baf5688c73aa9c00608e7a09b08]
@en